Medtronic announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable insulin ...

Abbott recently launched a smartphone app that works with both its FreeStyle Libre 2 and FreeStyle Libre 3 CGM systems.

Biolinq has completed its pivotal trial and submitted its wearable biosensor to the FDA for regulatory review.

Medtronic initially won FDA approval in August for its next-generation Simplera CGM. The Simplera platform includes the ...

Ypsomed announced today that it agreed to sell its diabetes care business to TecMed for up to approximately $517.7 million ...